News

Progress with transcatheter tricuspid valve replacement (TTVR) candidate devices Topaz, LuX-Valve Plus, VDyne, and Trisol for ...
The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.
St. Luke’s Heart Team pioneers first EVOQUE tricuspid valve replacement in the region, offering new hope for patients with ...
Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...
The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...
The global market for prosthetic heart valve is forecasted to attain USD 15,294.6 million by 2025, expanding at 7.5% CAGR to reach USD 31,522.6 million by 2035. In 2024, the revenue of prosthetic ...
Dr. Guy Fradet, MD, FACS, FRCSC, Cardiothoracic Surgeon, discusses heart valve replacement surgery. Secretary Bessent sends ...
Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne™ transcatheter mitral valve replacement (TMVR) system to treat people with mitral ...
Meril Life Sciences today announced one-year results from a pivotal trial evaluating its balloon-expandable Myval THV system.
Harry Potter star Miriam Margolyes has told fans she “doesn’t have long to live” after undergoing a heart operation.
An 11-year-old boy recently became the first person in the world to have an artificial heart valve replaced with a living ...
Nagpur: The city is witnessing a significant leap in cardiac care with the increasing use of Transcatheter Aortic Valve ...